首页> 美国卫生研究院文献>Mediators of Inflammation >Huang Qi Tong Bi Decoction Attenuates Myocardial Ischemia-Reperfusion Injury via HMGB1/TLR/NF-κB Pathway
【2h】

Huang Qi Tong Bi Decoction Attenuates Myocardial Ischemia-Reperfusion Injury via HMGB1/TLR/NF-κB Pathway

机译:黄芪通痹汤通过HMGB1 / TLR /NF-κB途径减轻心肌缺血再灌注损伤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this study was to study the protective effect of Huang Qi Tong Bi Decoction (HQTBT) on the heart of rats. Ischemia-reperfusion injury was established by coronary artery ligation. Proinflammatory cytokines were decreased by XFZY in coronary artery ligated rats. ST segment was also restored with the treatment of HQTBT. Triphenyltetrazole chloride (TTC) staining and pathological analysis showed that HQTBT reduced myocardial injury. Besides, the expressions of HMGB1/TLR/NF-κB pathway in rats were significantly decreased by HQTBT. This study shows that HQTBT inhibited inflammatory reaction on myocardial injury in rats.
机译:本研究的目的是研究黄芪通痹汤对大鼠心脏的保护作用。通过冠状动脉结扎建立缺血再灌注损伤。 XFZY可降低结扎冠状动脉大鼠的促炎细胞因子。 HQTBT治疗也恢复了ST段。氯化三苯四唑(TTC)染色和病理分析表明,HQTBT可减轻心肌损伤。此外,HQTBT显着降低了大鼠HMGB1 / TLR /NF-κB通路的表达。这项研究表明,HQTBT抑制了大鼠心肌损伤的炎症反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号